Research progresses in molecular mechanisms of TACE resistance of hepatocellular carcinoma
10.13929/j.issn.1672-8475.2025.06.013
- VernacularTitle:肝细胞癌TACE抵抗分子机制研究进展
- Author:
Boran LI
1
;
Li'ou ZHANG
Author Information
1. 中国医科大学第二临床学院,辽宁 沈阳 110122
- Publication Type:Journal Article
- Keywords:
carcinoma,hepatocellular;
chemoembolization,therapeutic
- From:
Chinese Journal of Interventional Imaging and Therapy
2025;22(6):425-428
- CountryChina
- Language:Chinese
-
Abstract:
TACE is a first-line treatment for unresectable intermediate-and advanced-stage hepatocellular carcinoma(HCC),but treatment resistance may be observed in some cases.At present,there is no unified standard for the definition of TACE resistance,and its molecular mechanism is not fully elucidated.The research progresses in molecular mechanism of TACE resistance of HCC were reviewed in this article.
